Andere talen SanBio Company Limited

Aandelen

4592

JP3336750009

Vertraagde tijd Japan Exchange Andere beurzen 08:00:00 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
430 ^JPY	+2,38%		+3,12%	-38,75%

19/03	SANBIO COMPANY LIMITED : Jefferies & Co. behoudt het verkoopadvies	ZM
19/03	Transcript : SanBio Company Limited, 2024 Earnings Call, Mar 19, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March	19/03
SanBio Books Non-operating Income, Extraordinary Gains, Deferred Income Taxes in Fiscal 2024	19/03
SanBio's FY2024 Attributable Net Loss Narrows on Lower Costs, Forex Gains	19/03
Sanbio Company Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending January 31, 2025, and Full Fiscal Year Ending January 31, 2025	18/03
SanBio Liquidates Singapore Unit	14/02
Sanbio Co., Ltd. Provides Update on Status of Manufacturing and Marketing Approval for Sb623 Chronic Traumatic Brain Injury Program in Japan	25/01
SanBio to Cancel Certain Stock Options	10/01
SanBio Logs Extraordinary Gain from Asset Sale of US Unit	21/12
Sanbio Widens Nine-Month Attributable Net Loss	15/12
Sanbio Cuts Staff Amid Restructuring of Overseas Subsidiary	15/12
Sanbio Expects to Receive Regulatory Nod for Stem Cell Therapy Candidate in March 2024	15/12
SanBio Company Limited Provides Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury Program in Japan	14/12
SanBio's Overseas Subsidiary to Carry Out Personnel Reduction by November	12-07-23
SanBio Co., Ltd. Updates on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury Program in Japan	14-06-23
SanBio Company Limited Provides Consolidated Earnings Guidance for the First Half and Full Year Ending January 31, 2024	14-06-23
Japan Stock Market Remains Jittery Despite Damage Control; Toyota Industries Plummets 11% Over Fresh Data Scandal	20-03-23
SanBio to Wind Up Singapore Unit	20-03-23
SanBio's FY23 Loss Widens	20-03-23
Sanbio Company Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending January 31, 2024, and Full Fiscal Year Ending January 31, 2024	17-03-23
SanBio to Acquire, Cancel Over 100,000 Stock Options	23-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen SanBio Company Limited

Aandelen

4592

JP3336750009

Andere talen

Filters